BSD Medical Corporation reported that Terumo Europe NV (Terumo) has obtained approvals to market and import the MicroThermX Microwave Ablation System in South Africa, Dubai, Qatar, and Jordan.
These approvals are part of Terumo’s comprehensive marketing strategy to expand MicroThermX distribution outside of Western Europe, a press release from BSD Medical states. The company’s exclusive, multimillion dollar agreement with Terumo covers distribution of the MicroThermX in more than 100 countries, including Europe, Western Asia and Africa, with a market potential that exceeds US$1 billion.
“Terumo is implementing a well-planned marketing strategy for the MicroThermX aimed at geographic expansion,” said Sam Maravich, vice president of International Sales and Marketing of BSD Medical. “We are gaining sales traction in the Western European countries. Terumo is an exceptional partner for BSD, making substantial investments in sales and marketing of the MicroThermX.”
